Introduction
Paroxysmal tonic spasms [PTS] are common in patients with neuromyelitis optica spectrum disorder (NMOSD). 1 2 In patients with demyelinating disease, PTS can significantly reduce the quality of life, limit activities of daily living and the rehabilitative process following an acute relapse. 3 As in patients with multiple sclerosis (MS), paroxysmal tonic spasms in NMOSD usually respond well to treatment with carbamazepine. 2 However, the optimal treatment in patients where carbamazepine is contraindicated or poorly tolerated is unclear. We describe a patient with NMOSD with severe paroxysmal tonic spasms who did not tolerate carbamazepine but was successfully treated with lacosamide (Vimpat). When it became apparent that the attacks were tonic spasms, she was started on carbamazepine with prompt resolution but five weeks later developed a generalised exfoliative erythematous rash. The clinical picture was consistent with Stevens-Johnson syndrome with toxic epidermal necrolysis. Carbamazepine was discontinued but within a week severe, frequent tonic spasms recurred.
Alternative sodium-channel blocking agents such as oxcarbazepine, phenytoin and lamotrigine were felt to be contraindicated because of a shared risk of developing StevensJohnson syndrome. She therefore commenced lacosamide 100mg daily and within 48 hours the tonic spasms were markedly improved and have subsequently ceased with no recurrence of the rash.
Discussion
PTS are stereotypical, recurrent, localized muscle spasms (in one or more limbs and/or the trunk), lasting between twenty seconds to three minutes, accompanied by severe pain and dystonia. They can have a significant impact on quality of life and rehabilitative potential thus require prompt diagnosis and treatment. 3 They frequently occur in patients with longitudinally extensive transverse myelitis secondary to NMOSD.
The pathophysiology of PTS is unclear and has been a matter of debate. In demyelinating disease, it is thought that demyelination renders axons hypersensitive to minor insults and subsequent irritation of these axons facilitates ephaptic transmission between demyelinated axons, resulting in PTS. 4 It has also been hypothesized that dysfunctional ion channels are involved in facilitating ephaptic transmission which may explain why sodium-channel blockers -such as carbamazepine -have been successfully used to suppress PTS in both MS and NMOSD. 6 SJS is a rare but well described adverse reaction to carbamazepine. 7 Because of the high rate of cross-reactivity with other commonly prescribed anticonvulsants and the previous failure of response to agents used for spasticity, treatment with lacosamide was tried. Lacosamide is a novel anticonvulsant that enhances the slow inactivation of voltage-gated sodium channels and is approved as adjunctive treatment for refractory focal-onset seizures. Although lacosamide can rarely cause a rash, there is no clear association with Stevens-Johnson syndrome. 8 The clear improvement in paroxysmal tonic spasms seen in this woman with NMOSD suggests that lacosamide can be an alternative treatment option in situations where carbamazepine is contraindicated or poorly tolerated.
